NEW YORK ( TheStreet) -- Parexel International Corporation (Nasdaq: PRXL) hit a new 52-week high Tuesday as it is currently trading at $28.93, above its previous 52-week high of $28.84 with 161,828 shares traded as of 12:05 p.m. ET. Average volume has been 412,300 shares over the past 30 days. Parexel International has a market cap of $1.71 billion and is part of the health care sector and health services industry. Shares are up 37.5% year to date as of the close of trading on Monday. PAREXEL International Corporation, a biopharmaceutical services company, provides a range of clinical research, medical communications, consulting, commercialization, and technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide. The company has a P/E ratio of 39.6, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Parexel International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Parexel International Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.